A Phase III Safety Study of Pro-NETU in Patients Receiving Highly Emetogenic Chemotherapy (Doxorubicin/Epirubicin and Cyclophosphamide): CONSOLE-BC

Name: A Phase III Safety Study of Pro-NETU in Patients Receiving Highly Emetogenic Chemotherapy (Doxorubicin/Epirubicin and Cyclophosphamide): CONSOLE-BC
Creator: Vivli
Published: 2025-05-01 01:02:07
License: 暂无描述

DataCite Commons2025-05-01 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/studies/PR00008730/isLanding

下载链接

链接失效反馈

官方服务：

资源简介：

This is a multicenter, randomized, double-blind, phase 3 study to examine the safety of single intravenously administration of Pro-NETU in combination with palonosetron and dexamethasone in patients receiving doxorubicin/cyclophosphamide (AC) or epirubicin/cyclophosphamide (EC) based HEC. For more information, visit: https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.34088

提供机构：

Vivli

创建时间：

2023-01-19